Prostaglandin I2 improved ET1-induced myocardial hypertrophy by activating IP prostaglandin-like receptor and cyclic adenosine monophosphate-dependent signal transduction in myocardial cells (33). The gene discussed is EDN1; the disease is cardiac hypertrophy.